Preclinical Imaging Market Research Report: By Product (Optical Imaging, Nuclear Imaging, Micro-MRI, Micro-Ultrasound, Micro-CT, Photoacoustic Imaging System), By Reagent (Optical, Nuclear, CT Contrast Agents, MRI Contrast Agents) - Forecast 2027
|ID: VPR/HC/1155||Publishing Year: January 2022||Pages: 118||Format:|
Preclinical Imaging Market Overview:
The Optical Preclinical Imaging Market is expected to rise rapidly due to the increasing use of optical imaging technologies for in vivo tests in drug development and the growing number of clinical research organisations (CRO). Additionally, the market is being driven by a surge in preclinical research funding from both the government and commercial organisations, targeted therapeutic development, and pharmaceutical companies collaborating with biotechnology. Furthermore, technological advancements will provide the Optical Preclinical Imaging Market with new development prospects.
Expanded public-private partnerships and funding for advanced research are the elements acknowledging the market development. Innovative breakthroughs in the realm of molecular imaging increased market interest for non-obtrusive small animal imaging approaches. The growing number of people interested in research and development, combined with the rapid pace of technological advancements, is driving the development of hybrid imaging frameworks, as well as the growth of clinical examination associations and organisations, which is driving the use of in-vivo imaging frameworks in Preclinical Research.
Some of the prominent players in the Global Preclinical Imaging Market are Bruker Corporation (US), MR Solutions (UK), PerkinElmer Inc. (US), Fujifilm Holdings Corporation (Japan), Milabs B.V. (The Netherlands), Mediso Ltd. (Hungary), LI-COR, Inc. (US), Miltenyi Biotec GmbH (Germany), Aspect Imaging (Israel), and Trifoil Imaging (US).
As a result of the growing number of clinical research organisations (CROs) and pharmaceutical companies, in-vivo imaging technologies are being more widely used in Preclinical Research, propelling the market's growth.
On the other side, the key factors hindering the market's growth are the restrictions placed on animal testing as a result of rules implemented by organisations that protect animal rights. Animal testing for cosmetics, for example, is prohibited in Europe. As a result, in-vitro tests, microdosing, computer-based models, virtual testing of new medications, and the construction of computerised databases for testing purposes are becoming increasingly popular.
The market for Preclinical Imaging is divided into two categories: modality and reagents. The growth of these sectors will assist you in analysing meagre growth segments in the industries, as well as providing users with a comprehensive market overview and industry insights to aid them in making strategic decisions for core market application identification.
Optical Imaging Systems, preclinical nuclear imaging systems, Micro-MRI systems, micro-ultrasound systems, micro-CT systems, preclinical photoacoustic imaging systems, and preclinical magnetic particle imaging (MPI) systems are the different types of Preclinical Imaging Systems.
Preclinical Imaging reagents, preclinical nuclear imaging reagents, preclinical MRI contrast agents, Preclinical ultrasound contrast agents, and preclinical CT Contrast agents are the different types of reagents used in Preclinical Imaging.
Because of the presence of well-established players, technological advancements in the field of molecular imaging, increasing market demand for non-invasive small-animal imaging techniques, and increased funding to support Preclinical Research, the Americas is expected to dominate the global preclinical imaging market. In the Worldwide Preclinical Imaging Market, Europe is predicted to have the second-largest share. Due to increased financing for Preclinical Research, Asia-Pacific is likely to be the fastest-growing market. Furthermore, in the worldwide Preclinical Imaging Market, the Middle East and Africa region is predicted to have the smallest market share.
The need for medical supplies is rising to meet the needs of the affected population. In primary clinical treatment, respiratory support equipment such as an atomizer, a life-support machine, an oxygen generator, and a monitor are among the most commonly used medical devices. Furthermore, COVID-19 has resulted in a significant increase in demand for medical goods such as masks, gloves, and protective spectacles. As the number of COVID-19 cases increases around the world, the demand for medical supplies from both healthcare professionals and the general public for preventative measures continues to climb. Manufacturers of these items have an opportunity to take advantage of the rising demand for medical supplies in order to assure a steady supply of personal protective equipment on the market.
Type Here for table of content.